This is a preview of subscription content, log in via an institution to check access.
Notes
proportion of glycosylated haemoglobin
2015 US dollars
Reference
Laiteerapong N, et al. Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Annals of Internal Medicine : 12 Dec 2017. Available from: URL: http://dx.doi.org/10.7326/M17-0537
Rights and permissions
About this article
Cite this article
Individualised glycaemic control cost saving in T2DM. PharmacoEcon Outcomes News 794, 16 (2018). https://doi.org/10.1007/s40274-018-4614-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4614-y